In the tissue samples of tumour patients from clinical sources, we used multiplex immunofluorescence to confirm that the proportion of NCL + B cells in IBC was significantly higher than that in nIBC (Fig. 7h), and there was a clear co-localization between PTN + tumour cells and NCL + B cells (Extended Data Fig. S11b). This evidence concerns the gene NUCLEOLIN and inflammatory breast carcinoma.